Replies to post #88 on Sol Global Investments Corp. (SOLCF)

[PotterBanker]

Scythian Biosciences Announces Execution of Share Purchase Agreement with MMJ International Investments Inc., owner of Argentina-based ABP S.A.

https://globenewswire.com/news-release/2018/09/14/1571118/0/en/Scythian-Biosciences-Announces-Execution-of-Share-Purchase-Agreement-with-MMJ-International-Investments-Inc-owner-of-Argentina-based-ABP-S-A.html

Execution of the Share Purchase Agreement is a Key Benchmark in Finalizing Previously Announced $193 Million Sale of Assets in Caribbean and Latin America

Shares to be Received in Consideration for the Proposed Sale of Assets in Caribbean and Latin America are now Worth Approximately $271 Million As Of Yesterday’s Close of Market

TORONTO, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl: SCCYF) announces that it has entered into a definitive share purchase agreement (the “Purchase Agreement”) with MMJ International Investments Inc. (“MMJ”), a privately-held British Columbia company and all of the shareholders of MMJ, to acquire all of the issued and outstanding common shares of MMJ (the “Acquisition”). MMJ is the owner of Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and distribution company with a license to import, sell and distribute medical products and derivatives in Argentina. ABP also holds a license to import cannabidiol oil into Argentina. The Purchase Agreement supersedes the previously-announced business combination agreement between Scythian and MMJ to effect the Acquisition. Closing of the Acquisition remains subject to a number of conditions including the receipt of all applicable regulatory approvals and third party consents and the completion of the Company’s due diligence investigations of MMJ and ABP.

[PotterBanker]

Scythian Biosciences Closes Acquisition of Marigold Projects Jamaica

https://globenewswire.com/news-release/2018/09/14/1570911/0/en/Scythian-Biosciences-Closes-Acquisition-of-Marigold-Projects-Jamaica.html

Closing Is Key Benchmark in Finalizing Previously Announced $193 Million Sale of
Assets in Caribbean and Latin America

Shares to Be Received in Consideration for the Proposed Sale of Assets in Caribbean and Latin America
Are Now Worth Approximately $271 Million Based on Price at Close of Market

TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl: SCCYF) has completed its acquisition of Marigold Acquisitions Inc., a privately-held British Columbia incorporated company (“Marigold Acquisitions”). As a result of the acquisition, Scythian now indirectly holds a 49% stake in Marigold Projects Jamaica Limited (“Marigold Jamaica”), a medical cannabis company that holds a tier 3 Cultivator’s license in Jamaica to produce cannabis for medicinal purposes.